FOX News – Health News | Health & Wellness

About 30% of Americans make at least one New Year’s resolution, statistics show — most often generally focused on exercising, eating healthier and losing weight.However, less than 10% of people stick with their resolutions throughout the year, with nearly a quarter quitting in the first week.To boost the success rate of resolutions, two doctors recommend pivoting from "quick fixes" and focusing more on science-based ways to achieve long-term wellness.SCIENTISTS REVEAL THE ONE PRACTICE THAT COULD PREVENT DEMENTIA AS YOU AGEDr. Shai Efrati, a leading expert in brain health and longevity, and Dr. Joseph Maroon, an 84-year-old NFL neurosurgeon and superager, shared the following six tips with Fox News Digital.Retirement can potentially accelerate physical and cognitive decline, Efrati warned, especially if it means withdrawing from meaningful activity. "Research consistently shows that continued engagement in work — whether full-time, part-time or even purpose-driven projects — is associated with better cognitive resilience, cardiovascular health… ...[TheTopNews] Read More.

Celebrities have been striving for health in 2025, with many dropping significant amounts of weight — in many cases with the help of GLP-1 medications like Ozempic.Below are four A-list stars who shared their weight-loss journeys this year, with or without the help of prescription drugs.Long-time talk show host Oprah Winfrey was recently featured in an exclusive interview with People Magazine, during which she discussed her weight loss and her new book, "Enough: Your Health, Your Weight and What It’s Like to Be Free."OPRAH WINFREY ADMITS SHE DRANK 17 SHOTS OF TEQUILA IN ONE NIGHT BEFORE GIVING UP ALCOHOL DUE TO GLP-1Winfrey, 71, began taking a GLP-1 medication in 2023 but attempted to quit just six months in to see if she could lose weight without it. Regardless of her diet and exercise routines, the media mogul said she still gained back 20 pounds after stopping the drug."It's going to… ...[TheTopNews] Read More.

A promising drug combination could help people with leukemia who don't respond to traditional treatments, according to new research.A team at Oregon Health and Science University made the discovery by analyzing samples from more than 300 patients with acute myeloid leukemia, or AML.More than 20,000 Americans are diagnosed with AML each year, making it one of the most common types of leukemia, data show. It is also one of the most aggressive.WHY ‘STARVING CANCER’ COULD BE KEY TO SLOWING DISEASE GROWTH, ACCORDING TO DOCTORSThe researchers paired venetoclax, a drug commonly used to treat leukemia, with palbociclib, which is used for breast cancer. This resulted in significantly stronger and more durable leukemia-fighting activity than venetoclax alone.The findings were confirmed in human tissue samples, as well as in mouse models carrying human leukemia cells."The data show that this drug regimen may be especially effective in patients whose tumors exhibit features that cause… ...[TheTopNews] Read More.

GLP-1 medications have dominated the weight-loss landscape this year — but some older Americans are reportedly kicking the trend to the curb.A study published in JAMA in January 2025 — which looked at more than 125,000 overweight or obese people — found that nearly 47% of those with type 2 diabetes and 65% of those without diabetes stopped taking their prescribed GLP-1s within a year of starting them.Dr. John Batsis, a geriatrician and obesity specialist at the University of North Carolina School of Medicine, told The New York Times in a recent report that people over 65 years old are "prime targets" for this medication, as obesity prevalence is about 40% in older adults.4 ANTI-AGING APPROACHES REVEALED IN 2025 THAT MAY HELP AMERICANS LIVE LONGERThese drugs, which mimic a natural gut hormone called GLP-1 (glucagon-like peptide-1), are primarily used for type 2 diabetes and weight management. However, they have also… ...[TheTopNews] Read More.

A large new study suggests that statins may help more people with type 2 diabetes than previously thought.Researchers found that the cholesterol-lowering drugs reduced the risk of death and serious cardiovascular events not only in high-risk patients, but also in those considered low-risk based on standard 10-year heart disease predictions, according to a press release.While statins are commonly prescribed to people with diabetes, there has been uncertainty about whether patients with a low predicted risk of cardiovascular disease would benefit from taking them.SIMPLE LIFESTYLE CHANGES COULD SLASH HEART ATTACK RISK FOR MILLIONS, SCIENTISTS REPORTTo explore this, researchers from the University of Hong Kong analyzed health records from a large U.K. medical database known as IQVIA Medical Research Data.The study included adults aged 25 to 84 with type 2 diabetes who had no serious heart disease or liver problems when the study began. Participants were followed for as long as 10… ...[TheTopNews] Read More.